Search results for " Depressive Disorder"

showing 10 items of 133 documents

Telomeres in the Brain Cortex of Patients with Major Depressive Disorder

2014

Telomeres are complex structures formed by the end of the DNA molecule at the tip of each chromosomal arm. The repeated (TTAGGG) telomeric sequence progressively shortens during lifespan because it cannot be replicated as somatic cells divide, and is highly susceptible to breakage by free radicals. Critically shortened telomeres activate the genetic program of cell senescence and/or apoptosis. The telomere length measured in peripheral blood leucocytes is considered a reliable marker of biological age, mortality risk and exposure to various pathological conditions, including cardiovascular disease, dementia, and metabolic syndrome. Telomere erosion has been observed in psychiatric disorders…

Senescencemedicine.medical_specialtybusiness.industryCognitive NeuroscienceDiseaseBioinformaticsmedicine.diseaseTelomereBehavioral NeurosciencePsychiatry and Mental healthNeurologyMood disordersSchizophreniamedicineMajor depressive disorderNeurology (clinical)businessPsychiatryPathologicalBiological PsychiatryDepression (differential diagnoses)Activitas Nervosa Superior
researchProduct

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Ps…

2018

AbstractPhysical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on health outcomes for people with SMI, including schizophrenia-spectrum disorders, major depressive disorder (MDD) and bipolar disorder. We searched major electronic databases until January 2018 for systematic reviews with/without meta-analysis that investigated PA for any SMI. We rated the quality of studies with the AMSTAR tool, grading the quality of evidence, and identifying gaps, future research needs and clinical practice recommendations.…

Societies Scientificmedicine.medical_specialtyCost effectivenessBipolar disorderPsychological interventionPsychosiMajor depressive disorder03 medical and health sciences0302 clinical medicineQuality of life (healthcare)mental disordersSevere mental illnessmedicineHumansBipolar disorderPsychiatryExerciseSocieties MedicalPsychiatryDepressive Disorder Majorbusiness.industryPhysical activitySedentary behaviourmedicine.diseaseMental illnessMental health030227 psychiatryPhysical TherapistsPsychiatry and Mental healthMental HealthSystematic reviewCardiorespiratory FitnessPsychotic DisordersQuality of LifeSchizophreniaMajor depressive disorderSchizophrenic Psychologybusiness030217 neurology & neurosurgery
researchProduct

A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric diso…

2016

Background The Temperament Evaluation Memphis, Pisa, Paris and San Diego Auto-questionnaire (TEMPS) is validated to assess temperament in clinical and non-clinical samples. Scores vary across bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), borderline personality disorder (BPD) and healthy controls (HCs), but a meta-analysis is missing. Methods Meta-analysis of studies comparing TEMPS scores in patients with mood disorders or their first-degree relatives to each other, or to a psychiatric control group or HCs. Results Twenty-six studies were meta-analyzed with patients with BD (n= 2025), MDD (n=1283), ADHD (n=56) and BPD (n=43), relati…

bipolar disorder (BDBipolar DisorderPersonality InventoryAffective temperament; Major depression: bipolar disorder; Temperament evaluation Memphis Pisa Paris and San Diego Auto-questionnaire 110 item version (TEMPS-A-110); TEMPS;Anxiety0302 clinical medicineSurveys and QuestionnairesSurveys and QuestionnaireBorderline personality disordermedia_commonAffective temperament; Major depression: bipolar disorder; Temperament evaluation Memphis Pisa Paris and San Diego Auto-questionnaire 110 item version (TEMPS-A-110); TEMPS; Psychiatry and Mental Health; Clinical PsychologyAffective temperamentmajor depressive disorder (MDD)Middle AgedCyclothymic DisorderIrritable MoodPsychiatry and Mental healthClinical PsychologyTEMPSMajor depressive disorderFemalePsychologyPsychometricHumanClinical psychologyAdultHyperthymic temperamentmedicine.medical_specialtyTemperament evaluation Memphis PisaAdolescentPsychometricsmedia_common.quotation_subjectbehavioral disciplines and activitiesNO03 medical and health sciencesYoung Adultmental disordersmedicineHumansFamilyMajor depression: bipolar disorderBipolar disorderMajor depression: bipolar disorder.PsychiatryTemperamentAgedDepressive Disorder MajorParis and San Diego Auto-questionnaire 110 item version (TEMPS-A-110)Cyclothymic Disordermedicine.disease030227 psychiatryAffectMoodMood disordersAttention Deficit Disorder with HyperactivityTemperamentTemperament evaluation Memphis Pisa Paris and San Diego Auto-questionnaire 110 item version (TEMPS-A-110)030217 neurology & neurosurgeryJournal of affective disorders
researchProduct

Is There an Advantage to Venlafaxine in Comparison with Other Antidepressants?

1997

The purpose of this article is to compare and contrast the benefits and limitations of antidepressant drugs. Several different classes of antidepressants are available for treatment of major depressive disorder, each with its own benefits and limitations as a result of its pharmacological profile. Tricyclic antidepressants (TCAs) and monoamine oxidase (MAO) inhibitors are effective in a large proportion of depressed patients, but their use is often limited by short- and long-term safety/tolerability problems. Selective serotonin reuptake inhibitors (SSRIs) exhibit comparable efficacy to TCAs in most patients, but may be less effective in certain patients. Additionally, SSRI use may by impac…

chemistry.chemical_classificationbusiness.industryVenlafaxinePharmacologymedicine.diseasePsychiatry and Mental healthNeurologychemistryTolerabilitymedicineAntidepressantMajor depressive disorderAnxietyPharmacology (medical)Neurology (clinical)Onset of actionmedicine.symptomReuptake inhibitorbusinessTricyclicmedicine.drugHuman Psychopharmacology: Clinical and Experimental
researchProduct

Platelet and Plasmatic Lipidic Profile as Potential Marker of Bipolar Disorders: Preliminary Findings

2017

IntroductionAlthough the diagnosis of bipolar disorder is currently based on clinical criteria, preliminary studies showed that palmitic and arachidonic acid levels are able to discriminate adult patients with major depressive disorder (MDD) from those with bipolar disorder (BD).ObjectivesTo replicate and to expand previous findings by investigating the relation between mood disorders and platelet and plasmatic fatty levels.AimsTo compare the lipidic profile of individuals with different mood disorder (MDD vs. BD) and to investigate the relation with specific clinical features (duration of illness, attempted suicide, psychotic symptoms).MethodsPotential participants were recruited from the …

chemistry.chemical_classificationmedicine.medical_specialtymajor depressive disordersalpha-Linolenic acidFatty acidstearic acidmedicine.diseasePsychiatry and Mental healthchemistry.chemical_compoundMoodchemistryMood disordersDocosahexaenoic acidInternal medicinemedicineMajor depressive disorderArachidonic acidBipolar disorderPsychologyPsychiatryarachidonicEuropean Psychiatry
researchProduct

The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions

2017

Cardio-vascular diseases (CVDs) and CVD-related disorders (including cerebrovascular diseases; CBVDs) are a major public health concern as they represent the leading cause of mortality and morbidity in developed countries. Patients with CVDs and CBVDs co-morbid with mood disorders, especially bipolar disorder (BD) and major depressive disorder (MDD), suffer reduced quality-of-life and significant disability adjusted for years of life and mortality. The relationship between CVDs/CBVDs and mood disorders is likely to be bidirectional. Evidence for shared genetic risk of pathways involved in stress reaction, serotonin or dopamine signalling, circadian rhythms, and energy balance was reported i…

cognitionmedicine.medical_specialtyPsychological interventionphysical activity03 medical and health sciences0302 clinical medicineNeurobiologycardiovascular diseasemental disordersmedicineHumansBipolar disorderPsychiatrybipolar disorderpsychopharmacologyexerciseMood DisordersDepression; bipolar disorder; cardiovascular disease; cognition; comorbidity; exercise; physical activity; psychopharmacology; quality-of-life; strokeDepressionmedicine.diseaseComorbiditystroke030227 psychiatryCerebrovascular DisordersPsychiatry and Mental healthcomorbidityMoodHypomaniaMood disordersquality-of-lifeMajor depressive disordermedicine.symptomPsychologybipolar disorder; cardiovascular disease; cognition; comorbidity; Depression; exercise; physical activity; psychopharmacology; quality-of-life; strokeMania030217 neurology & neurosurgeryClinical psychology
researchProduct

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials

2019

The role of nutrition in mental health is becoming increasingly acknowledged. Along with dietary intake, nutrition can also be obtained from "nutrient supplements", such as polyunsaturated fatty acids (PUFAs), vitamins, minerals, antioxidants, amino acids and pre/probiotic supplements. Recently, a large number of meta-analyses have emerged examining nutrient supplements in the treatment of mental disorders. To produce a meta-review of this top-tier evidence, we identified, synthesized and appraised all meta-analyses of randomized controlled trials (RCTs) reporting on the efficacy and safety of nutrient supplements in common and severe mental disorders. Our systematic search identified 33 me…

eicosapentaenoic acidNutrient supplements polyunsaturated fatty acids omega-3 eicosapentaenoic acid methylfolate vitamin D N-acetylcysteine depression schizophrenia attention-deficit/hyperactivity disorder adjunctive treatmentvitamin Dlaw.invention0302 clinical medicineRandomized controlled triallawL-METHYLFOLATEVITAMIN-D SUPPLEMENTATIONOXIDATIVE STRESSPsychiatryMAJOR DEPRESSIVE DISORDERPOLYUNSATURATED FATTY-ACIDSattention-deficitGUT MICROBIOTAPsychiatry and Mental healthNutrient supplementsCARDIOVASCULAR-DISEASESchizophreniadepressionhyperactivity disorderMajor depressive disorderomega-3Pshychiatric Mental HealthLife Sciences & Biomedicinepolyunsaturated fatty acidsmedicine.medical_specialtyDEFICIT HYPERACTIVITY DISORDERattention-deficit/hyperactivity disorder03 medical and health sciencesmedicineAttention deficit hyperactivity disorderPsychiatryAdverse effectIntensive care medicineScience & Technologybusiness.industrymethylfolateadjunctive treatmentResearch Reportsmedicine.diseaseNUTRITIONAL MEDICINEMental healthN-acetylcysteine030227 psychiatryschizophreniaMood disordersAdjunctive treatmentbusiness030217 neurology & neurosurgeryWorld Psychiatry
researchProduct

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta…

2017

Mounting evidence suggests that aberrations in immune-inflammatory pathways contribute to the pathophysiology of major depressive disorder (MDD), and individuals with MDD may have elevated levels of predominantly pro-inflammatory cytokines and C-reactive protein. In addition, previous meta-analyses suggest that antidepressant drug treatment may decrease peripheral levels of interleukin-1 beta (IL-1β) and IL-6. Recently, several new studies examining the effect of antidepressants on these cytokines have been published, and so we performed an updated meta-analysis of studies that measured peripheral levels of cytokines and chemokines during antidepressant treatment in patients with MDD. The P…

epressionChemokinemedicine.drug_classmedicine.medical_treatmentNeuroscience (miscellaneous)InflammationAntidepressantPharmacology03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineHumansMeta-analysiCytokineInflammationDepressive Disorder MajorbiologyDepressionbusiness.industrymedicine.diseaseReceptor antagonistAntidepressive Agents030227 psychiatryMeta-analysisCytokineTreatment OutcomeAntidepressant; Chemokines; Cytokines; Depression; Inflammation; Meta-analysis; Cellular and Molecular NeuroscienceNeurologyChemokineMeta-analysisbiology.proteinCytokinesMajor depressive disorderAntidepressantTumor necrosis factor alphamedicine.symptomChemokinesbusiness030217 neurology & neurosurgeryMolecular neurobiology
researchProduct

the role of antidepressant treatments on cognitive deficits: a review of recent literature

2011

Objective: Nowadays, the interaction between cognition and emotions during a depressive disorder in an area of interest in the scientific literature. Patients with major depressive disorder (MDD) usually show alterations in various cognitive functions: attention, working memory, mental processing speed, executive functions. Clinical observation of the effects of cognitive deficits on quality of life in patients with MDD, in euthymic and relapse phases, needs a review of recent scientific literature on the impact of antidepressant treatment as a protective factor of the improvement of cognitive performances. Methods: Electronic PubMed and PsycInfo searches were conducted to identify research…

major depressive disorder cognition antidepressants neuropsychology
researchProduct

Motor imagery in unipolar major depression

2014

International audience; Background: Motor imagery is a potential tool to investigate action representation, as it can provide insights into the processes of action planning and preparation. Recent studies suggest that depressed patients present specific impairment in mental rotation. The present study was designed to investigate the influence of unipolar depression on motor imagery ability. Methods: Fourteen right-handed patients meeting DSM-IV criteria for unipolar depression were compared to 14 matched healthy controls. Imagery ability was accessed by the timing correspondence between executed and imagined movements during a pointing task, involving strong spatiotemporal constraints (spee…

major depressive disorderspeed/accuracy trade offPREDICTIONCognitive NeuroscienceMULTIPLE-SCLEROSISPERFORMANCEBehavioral NeuroscienceNeuropsychology and Physiological Psychologymotor imageryTEMPORAL FEATURESPARKINSONS-DISEASEmovement speedSIMULATIONmental chronometryHAND MOVEMENTSARMPSYCHOMOTOR RETARDATIONANHEDONIA[ SCCO ] Cognitive scienceNeuroscience
researchProduct